76 related articles for article (PubMed ID: 38498065)
21. Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment.
Goel NJ; Bird CE; Hicks WH; Abdullah KG
J Med Econ; 2021; 24(1):1018-1024. PubMed ID: 34353213
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative B-Mode Ultrasound Guided Surgery and the Extent of Glioblastoma Resection: A Randomized Controlled Trial.
Incekara F; Smits M; Dirven L; Bos EM; Balvers RK; Haitsma IK; Schouten JW; Vincent AJPE
Front Oncol; 2021; 11():649797. PubMed ID: 34094939
[TBL] [Abstract][Full Text] [Related]
23. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
BMJ; 2021 Mar; 372():n71. PubMed ID: 33782057
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis.
Fountain DM; Bryant A; Barone DG; Waqar M; Hart MG; Bulbeck H; Kernohan A; Watts C; Jenkinson MD
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013630. PubMed ID: 33428222
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
Domino JS; Ormond DR; Germano IM; Sami M; Ryken TC; Olson JJ
J Neurooncol; 2020 Nov; 150(2):121-142. PubMed ID: 33215341
[TBL] [Abstract][Full Text] [Related]
26. 5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery.
Della Pepa GM; Ius T; La Rocca G; Gaudino S; Isola M; Pignotti F; Rapisarda A; Mazzucchi E; Giordano C; Dragonetti V; Chiesa S; Balducci M; Gessi M; Skrap M; Olivi A; Marchese E; Sabatino G
Neurosurgery; 2020 Jun; 86(6):E529-E540. PubMed ID: 32186345
[TBL] [Abstract][Full Text] [Related]
27. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.
Marenco-Hillembrand L; Wijesekera O; Suarez-Meade P; Mampre D; Jackson C; Peterson J; Trifiletti D; Hammack J; Ortiz K; Lesser E; Spiegel M; Prevatt C; Hawayek M; Quinones-Hinojosa A; Chaichana KL
J Neurooncol; 2020 Apr; 147(2):297-307. PubMed ID: 32157552
[TBL] [Abstract][Full Text] [Related]
28. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
[TBL] [Abstract][Full Text] [Related]
29. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Cumpston M; Li T; Page MJ; Chandler J; Welch VA; Higgins JP; Thomas J
Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000142. PubMed ID: 31643080
[No Abstract] [Full Text] [Related]
30. RoB 2: a revised tool for assessing risk of bias in randomised trials.
Sterne JAC; Savović J; Page MJ; Elbers RG; Blencowe NS; Boutron I; Cates CJ; Cheng HY; Corbett MS; Eldridge SM; Emberson JR; Hernán MA; Hopewell S; Hróbjartsson A; Junqueira DR; Jüni P; Kirkham JJ; Lasserson T; Li T; McAleenan A; Reeves BC; Shepperd S; Shrier I; Stewart LA; Tilling K; White IR; Whiting PF; Higgins JPT
BMJ; 2019 Aug; 366():l4898. PubMed ID: 31462531
[No Abstract] [Full Text] [Related]
31. Navigated Intraoperative 2-Dimensional Ultrasound in High-Grade Glioma Surgery: Impact on Extent of Resection and Patient Outcome.
Moiraghi A; Prada F; Delaidelli A; Guatta R; May A; Bartoli A; Saini M; Perin A; Wälchli T; Momjian S; Bijlenga P; Schaller K; DiMeco F
Oper Neurosurg (Hagerstown); 2020 Apr; 18(4):363-373. PubMed ID: 31435672
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland.
Korja M; Raj R; Seppä K; Luostarinen T; Malila N; Seppälä M; Mäenpää H; Pitkäniemi J
Neuro Oncol; 2019 Feb; 21(3):370-379. PubMed ID: 30312433
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative imaging technology to maximise extent of resection for glioma.
Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
[TBL] [Abstract][Full Text] [Related]
34. Lomustine and Bevacizumab in Progressive Glioblastoma.
Wick W; Gorlia T; Bendszus M; Taphoorn M; Sahm F; Harting I; Brandes AA; Taal W; Domont J; Idbaih A; Campone M; Clement PM; Stupp R; Fabbro M; Le Rhun E; Dubois F; Weller M; von Deimling A; Golfinopoulos V; Bromberg JC; Platten M; Klein M; van den Bent MJ
N Engl J Med; 2017 Nov; 377(20):1954-1963. PubMed ID: 29141164
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
[TBL] [Abstract][Full Text] [Related]
36. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Sterne JA; Hernán MA; Reeves BC; Savović J; Berkman ND; Viswanathan M; Henry D; Altman DG; Ansari MT; Boutron I; Carpenter JR; Chan AW; Churchill R; Deeks JJ; Hróbjartsson A; Kirkham J; Jüni P; Loke YK; Pigott TD; Ramsay CR; Regidor D; Rothstein HR; Sandhu L; Santaguida PL; Schünemann HJ; Shea B; Shrier I; Tugwell P; Turner L; Valentine JC; Waddington H; Waters E; Wells GA; Whiting PF; Higgins JP
BMJ; 2016 Oct; 355():i4919. PubMed ID: 27733354
[TBL] [Abstract][Full Text] [Related]
37. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Brown TJ; Brennan MC; Li M; Church EW; Brandmeir NJ; Rakszawski KL; Patel AS; Rizk EB; Suki D; Sawaya R; Glantz M
JAMA Oncol; 2016 Nov; 2(11):1460-1469. PubMed ID: 27310651
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative Ultrasound-Guided Resection of Gliomas: A Meta-Analysis and Review of the Literature.
Mahboob S; McPhillips R; Qiu Z; Jiang Y; Meggs C; Schiavone G; Button T; Desmulliez M; Demore C; Cochran S; Eljamel S
World Neurosurg; 2016 Aug; 92():255-263. PubMed ID: 27178235
[TBL] [Abstract][Full Text] [Related]
39. Survival in glioblastoma: a review on the impact of treatment modalities.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2016 Nov; 18(11):1062-1071. PubMed ID: 26960561
[TBL] [Abstract][Full Text] [Related]
40. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
